|
Kythera Biopharmaceuticals |
|
|
27200 West Agoura Road, Suite 200 Calabasas,, CA 91301 USA phone:(818) 587-4500 fax:(818) 587-4591
|
|
| Symbol |
Private |
| Founded |
2005 |
| Employees |
|
|
|
| www.kytherabiopharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Focused on science and innovation in aesthetic and restorative dermatology
|
 |
| Management |
| Keith Leonard, President and Chief Executive Officer; Deepak Chadha, Vice President, Regulatory Affairs; Nathaniel "Ned" David, Phd, Chief Science Officer; Amit Munshi, Chief Business Officer; John Smither, Chief Financial Officer; Patricia Walker, MD, PhD, Chief Medical Officer; Jeff Webster, Vice President, Product Development and Operations; Keith Klein, General Counsel
|
| |
|
|
| |
|
| Keywords |
| Aesthetics, plastic surgery, skin care |
|
|
|
| Description |
|
Kythera is focused on science and innovation in aesthetic and restorative dermatology. |
 |
| Products / Services |
The company will have multiple products entering clinical trials by year end 2006 and several ongoing preclinical stage programs.
|
 |
| Technology / Differentiation |
| Kythera uses the tools of biotechnology to develop prescription therapeutics for the emerging aesthetic and restorative dermatology market. |
 |
| Market / Customers |
The market is characterized by growth in demand driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care.
|
 |
| Funding |
| In July 2006 raised $30 million in a Series B financing. The financing was co-led by Prospect Venture Partners and ARCH Venture Partners. Prospect joins existing investors Versant Ventures and ARCH Venture Partners. Also investing in the round were Altitude Life Science Ventures, the UCLA Venture Fund and the Wilson Sonsini Goodrich and Rosati Investment Company. |
 |
|
|
|
|
|
|